Baxter Recalls Nitroglycerin in Dextrose Injection

Baxter announced a voluntary recall of one lot of Nitroglycerin in 5% Dextrose Injection after particulate matter was found in one vial. 

RELATED: Cardiovascular Disease Resource Center

Infusion of particulate matter can lead to potential venous and/or arterial thromboembolism, inflammation, and local irritation of blood vessels.

Nitroglycerin in 5% Dextrose Injection is indicated for treatment of perioperative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and β-blockers; and for induction of intraoperative hypotension.

The affected Nitroglycerin in 5% Dextrose Injection is supplied as 250mL glass containers in 12-count cartons with product code 1A0694 and lot # G105197. Baxter is notifying customers to not use the product from the recalled lot. 

For more information call (888) 229-0001 or visit the FDA Safety Alert page.